389 related articles for article (PubMed ID: 27720639)
1. Irradiation of breast cancer cells enhances CXCL16 ligand expression and induces the migration of natural killer cells expressing the CXCR6 receptor.
Yoon MS; Pham CT; Phan MT; Shin DJ; Jang YY; Park MH; Kim SK; Kim S; Cho D
Cytotherapy; 2016 Dec; 18(12):1532-1542. PubMed ID: 27720639
[TBL] [Abstract][Full Text] [Related]
2. [Expressions of CXCL16/CXCR6 and CXCL12/CXCR4 in first-trimester human trophoblast cells].
Huang Y; Li DJ; Wang MY; Cheng HD
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):399-402. PubMed ID: 16831364
[TBL] [Abstract][Full Text] [Related]
3. CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms.
Xiao G; Wang X; Wang J; Zu L; Cheng G; Hao M; Sun X; Xue Y; Lu J; Wang J
Oncotarget; 2015 Jun; 6(16):14165-78. PubMed ID: 25909173
[TBL] [Abstract][Full Text] [Related]
4. CXC chemokine ligand 16 in periodontal diseases: expression in diseased tissues and production by cytokine-stimulated human gingival fibroblasts.
Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
Clin Exp Immunol; 2007 Jul; 149(1):146-54. PubMed ID: 17459077
[TBL] [Abstract][Full Text] [Related]
5. CXCL16 and CXCR6 in Ewing sarcoma family tumor.
Na KY; Kim HS; Jung WW; Sung JY; Kalil RK; Kim YW; Park YK
Hum Pathol; 2014 Apr; 45(4):753-60. PubMed ID: 24507753
[TBL] [Abstract][Full Text] [Related]
6. Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues.
Nakayama T; Hieshima K; Izawa D; Tatsumi Y; Kanamaru A; Yoshie O
J Immunol; 2003 Feb; 170(3):1136-40. PubMed ID: 12538668
[TBL] [Abstract][Full Text] [Related]
7. Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma.
Guo L; Cui ZM; Zhang J; Huang Y
Chin J Cancer; 2011 May; 30(5):336-43. PubMed ID: 21527066
[TBL] [Abstract][Full Text] [Related]
8. CXCL16 and CXCR6 are coexpressed in human lung cancer in vivo and mediate the invasion of lung cancer cell lines in vitro.
Hu W; Liu Y; Zhou W; Si L; Ren L
PLoS One; 2014; 9(6):e99056. PubMed ID: 24897301
[TBL] [Abstract][Full Text] [Related]
9. The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers.
Darash-Yahana M; Gillespie JW; Hewitt SM; Chen YY; Maeda S; Stein I; Singh SP; Bedolla RB; Peled A; Troyer DA; Pikarsky E; Karin M; Farber JM
PLoS One; 2009 Aug; 4(8):e6695. PubMed ID: 19690611
[TBL] [Abstract][Full Text] [Related]
10. The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation.
Meijer J; Ogink J; Kreike B; Nuyten D; de Visser KE; Roos E
Cancer Res; 2008 Jun; 68(12):4701-8. PubMed ID: 18559516
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis.
Nanki T; Shimaoka T; Hayashida K; Taniguchi K; Yonehara S; Miyasaka N
Arthritis Rheum; 2005 Oct; 52(10):3004-14. PubMed ID: 16200580
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival.
Hald SM; Kiselev Y; Al-Saad S; Richardsen E; Johannessen C; Eilertsen M; Kilvaer TK; Al-Shibli K; Andersen S; Busund LT; Bremnes RM; Donnem T
BMC Cancer; 2015 May; 15():441. PubMed ID: 26021984
[TBL] [Abstract][Full Text] [Related]
13. Expression and regulation of the chemokine CXCL16 in Crohn's disease and models of intestinal inflammation.
Diegelmann J; Seiderer J; Niess JH; Haller D; Göke B; Reinecker HC; Brand S
Inflamm Bowel Dis; 2010 Nov; 16(11):1871-81. PubMed ID: 20848509
[TBL] [Abstract][Full Text] [Related]
14. CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and αvβ3 integrin clustering.
Singh R; Kapur N; Mir H; Singh N; Lillard JW; Singh S
Oncotarget; 2016 Feb; 7(6):7343-53. PubMed ID: 26799186
[TBL] [Abstract][Full Text] [Related]
15. CXCR6/CXCL16 functions as a regulator in metastasis and progression of cancer.
Deng L; Chen N; Li Y; Zheng H; Lei Q
Biochim Biophys Acta; 2010 Aug; 1806(1):42-9. PubMed ID: 20122997
[TBL] [Abstract][Full Text] [Related]
16. Expression of the CXCL12/CXCR4 and CXCL16/CXCR6 axes in cervical intraepithelial neoplasia and cervical cancer.
Huang Y; Zhang J; Cui ZM; Zhao J; Zheng Y
Chin J Cancer; 2013 May; 32(5):289-96. PubMed ID: 22958742
[TBL] [Abstract][Full Text] [Related]
17. Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis.
Rabquer BJ; Tsou PS; Hou Y; Thirunavukkarasu E; Haines GK; Impens AJ; Phillips K; Kahaleh B; Seibold JR; Koch AE
Arthritis Res Ther; 2011 Feb; 13(1):R18. PubMed ID: 21303517
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity.
Gooden MJ; Wiersma VR; Boerma A; Leffers N; Boezen HM; ten Hoor KA; Hollema H; Walenkamp AM; Daemen T; Nijman HW; Bremer E
Br J Cancer; 2014 Mar; 110(6):1535-44. PubMed ID: 24518602
[TBL] [Abstract][Full Text] [Related]
19. CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells.
Hu W; Zhen X; Xiong B; Wang B; Zhang W; Zhou W
Cancer Sci; 2008 Jul; 99(7):1362-9. PubMed ID: 18452560
[TBL] [Abstract][Full Text] [Related]
20. Activating and inhibitory Ly49 receptors modulate NK cell chemotaxis to CXC chemokine ligand (CXCL) 10 and CXCL12.
Inngjerdingen M; Rolstad B; Ryan JC
J Immunol; 2003 Sep; 171(6):2889-95. PubMed ID: 12960311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
